AVNeo

AVNeo (Aortic Valve Neocuspidization) is a standardized revolutionary procedural technique used to reconstruct the aortic heart valve using the patient’s own pericardial tissue. Partnering with Sanamedi and Saudi Arabian Ministry of Health, Abdul Latif Jameel Health has introduced this pioneering life saving procedure into Saudi Arabia.

AVNeo™ Sizer System

For Aortic Valve Reconstruction Surgery. The AVNeo™ Sizer System is a single-use device used to perform an aortic valve neocuspidization required for aortic valve diseases, including aortic stenosis and aortic insufficiency (with or without infective endocarditis). The Sizer System allows surgeons to measure the distance between the native aortic valve commissures to determine the appropriate size of the replacement heart valve leaflets for cardiac valve reconstruction utilizing the patient’s autologous pericardium or similar tissues from the patients’ own body.

Sizer System

Enhanced User-friendliness

The single-use Sizer System is compact and includes necessary tools, such as a glutaraldehyde tray and plate for pericardium treatment and a tri-compartment petri-dish to maintain the treated, trimmed cusps before use. Sizer sets are available in three sizes; Standard (19/21/23/25/27/29 mm), Small (13/15/17 mm) and Large (31/33/35 mm).

Template for Reproducibility and Precision

The template, which provides for 12 cusp sizes, enables both precise trimming of the cusps and guiding of suturing and commissure reinforcement.

The AVNeo™ Procedure
Perfecting the Art of Natural Aortic Valve Flow

Professor Ozaki began using this highly standardized technique on aortic valve (AV) disease patients in Japan in 2007. Today, the AVNeo™ Procedure is practiced all over the world because of its unique benefits to the patient and its reproducibility. As of December 2022, more than 6,200 patients have been treated using the AVNeo™ Sizer System.

The AVNeo™ Procedure could be a suitable solution for patients suffering from aortic valve diseases who are eligible to undergo open heart surgery, which might be ideal for treating the small annulus and patients who need to avoid anticoagulation therapy.

Certifications:

  • AVNeo has received its Saudi Food And Drug Authority’s Medical Device Marketing Authorization MDMA-1-2021-1923
  • AVNeo has received American FDA number, registration number 3010805418.
  • AVNeo has received CE Mark approval.

For more Inquiries and Information related to our products

Get in touch